Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol

BACKGROUND: A tenosynovial giant cell tumor (TGCT) is a locally aggressive benign neoplasm arising from intra- or extra-articular tissue. Diffuse TGCT (D-TGCT) most commonly develops in the knee, followed by the hip, ankle, elbow, and shoulder. Surgical removal is the only effective treatment option...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Akihiko, Nomura, Akihiro, Yamamoto, Norio, Hayashi, Katsuhiro, Igarashi, Kentaro, Tandai, Susumu, Kawai, Akira, Matsumine, Akihiko, Miwa, Shinji, Nishida, Yoshihiro, Nakamura, Tomoki, Terauchi, Ryu, Hoshi, Manabu, Kunisada, Toshiyuki, Endo, Makoto, Yoshimura, Kenichi, Murayama, Toshinori, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368706/
https://www.ncbi.nlm.nih.gov/pubmed/30738433
http://dx.doi.org/10.1186/s12891-019-2453-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368706/
https://www.ncbi.nlm.nih.gov/pubmed/30738433
http://dx.doi.org/10.1186/s12891-019-2453-z

Ejemplares similares